Synthesis and structure-activity relationships of cetiedil analogues as blockers of the Ca(2+)-activated K+ permeability of erythrocytes
- PMID: 11563923
- DOI: 10.1021/jm001113w
Synthesis and structure-activity relationships of cetiedil analogues as blockers of the Ca(2+)-activated K+ permeability of erythrocytes
Abstract
Cetiedil, [2-cyclohexyl-2-(3-thienyl)ethanoic acid 2-(hexahydro-1H-azepin-1-yl)ethyl ester], which blocks the intermediate calcium-activated potassium ion permeability (IK(Ca)) in red blood cells, was used as a lead for investigating structure-activity relationships with the aim of determining the pharmacophore and of synthesizing agents of greater potency. A series of compounds having structures related to cetiedil was made and tested on rabbit erythrocytes. Channel blocking activity within the series was found to correlate well with octanol-water partition coefficients but not with the specific chemical structure of the acid moiety. However, whereas log P for the compounds spans a range of values over 4 orders of magnitude, potency only increases by 2 orders. This suggests that hydrophobic interactions with an active site on the channel are probably not the main determinants of activity. It seems more likely that increased lipophilicity enhances access to the channel, probably from within the cell membrane. In keeping with this interpretation, cetiedil methoiodide was found to be inactive. Triphenylethanoic was found to be a more effective acid grouping than 2-cyclohexyl-2-(3-thienyl)ethanoic, and its 2-(hexahydro-1H-azepin-l-yl)ethyl ester (11) was approximately 3 times more potent than cetiedil. The 9-benzylfluoren-9-yl carboxylic acid ester (21) was found to be approximately 9 times more active than cetiedil, and replacing -CO(2)- in 21 by an ethynyl (-C identical to C-) linkage (compound 26, UCL 1608) increased potency by some 15-fold over that of cetiedil.
Similar articles
-
The synthesis and some pharmacological actions of the enantiomers of the K(+)-channel blocker cetiedil.J Pharm Pharmacol. 1996 Aug;48(8):851-7. doi: 10.1111/j.2042-7158.1996.tb03986.x. J Pharm Pharmacol. 1996. PMID: 8887737
-
Differences in the actions of some blockers of the calcium-activated potassium permeability in mammalian red cells.Br J Pharmacol. 1999 Jan;126(1):169-78. doi: 10.1038/sj.bjp.0702292. Br J Pharmacol. 1999. PMID: 10051133 Free PMC article.
-
Inhibition of the antigen-induced activation of RBL-2H3 cells by cetiedil and some of its analogues.Eur J Pharmacol. 2004 Jan 12;483(2-3):107-16. doi: 10.1016/j.ejphar.2003.10.014. Eur J Pharmacol. 2004. PMID: 14729097
-
Effect of cetiedil on erythrocyte sickling: new type of antisickling agent that may affect erythrocyte membranes.Proc Natl Acad Sci U S A. 1980 May;77(5):2955-9. doi: 10.1073/pnas.77.5.2955. Proc Natl Acad Sci U S A. 1980. PMID: 6930678 Free PMC article.
-
A new therapeutic approach for sickle cell disease. Blockade of the red cell Ca(2+)-activated K+ channel by clotrimazole.Ann N Y Acad Sci. 1995 Jul 12;763:262-71. doi: 10.1111/j.1749-6632.1995.tb32411.x. Ann N Y Acad Sci. 1995. PMID: 7677336 Review. No abstract available.
Cited by
-
Genetic neural network modeling of the selective inhibition of the intermediate-conductance Ca2+ -activated K+ channel by some triarylmethanes using topological charge indexes descriptors.J Comput Aided Mol Des. 2005 Nov;19(11):771-89. doi: 10.1007/s10822-005-9025-z. Epub 2005 Dec 23. J Comput Aided Mol Des. 2005. PMID: 16374673
-
Expression and Role of the Intermediate-Conductance Calcium-Activated Potassium Channel KCa3.1 in Glioblastoma.J Signal Transduct. 2012;2012:421564. doi: 10.1155/2012/421564. Epub 2012 May 17. J Signal Transduct. 2012. PMID: 22675627 Free PMC article.
-
Chemoselective Carbonyl Allylations with Alkoxyallylsiletanes.J Org Chem. 2019 Apr 5;84(7):4421-4428. doi: 10.1021/acs.joc.8b03028. Epub 2019 Mar 13. J Org Chem. 2019. PMID: 30811929 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous